Poland· PL-100352517
Belkyra
A deoxycholic acid product containing acidum deoxycholicum, registered in Poland by AbbVie Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Deoxycholic acid is registered in 7 of 19 countries.
Countries holding a registration under ATC D11AX24 (deoxycholic acid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Deoxycholic acid · ATC D11AX24
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum deoxycholicum
- Manufacturer
- AbbVie Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D11AX24
- ATC class
- Deoxycholic acid
- Defined daily dose
- 1.79 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991304768
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
79 interactions on record for deoxycholic acid.
Graded by severity as the source publishes them — 79 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deoxycholic acid · interactions on record
79 records
- 79 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deoxycholic acid in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBELKYRA 10 MG/ML SOLUCION INYECTABLEAbbvie Spain, S.L.U.
- SwedenBelkyra 10 mg/ml Injektionsvätska, lösningAbbVie AB
- United StatesKYBELLAKythera Biopharmaceuticals Inc.
- FinlandBelkyraAbbVie Oy
- CanadaBELKYRAABBVIE CORPORATION
- NetherlandsBelkyra 10 mg/ml, oplossing voor injectieAbbVie B.V.
- United KingdomBelkyra 20mg/2ml solution for injection vialsAllergan Ltd
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Belkyra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7cf935e0-3402-412f-b9c9-7ea20c5f37e8 GET /v1/drugs/7cf935e0-3402-412f-b9c9-7ea20c5f37e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "10 mg/ml",
"packaging": "05909991304768 ¦ Rpz ¦ 118934\n4 fiol. 2 ml",
"substance": "Acidum deoxycholicum 10 mg/ml",
"common_name": "Acidum deoxycholicum",
"pl_product_id": "100352517",
"pozwolenie_nr": "23575",
"auth_procedure": "DCP",
"authorisation_validity": "2024-02-06"
}See everything about deoxycholic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.